Immunotherapy and multiple sclerosis: The devil is in the details

Neurology

Volumn 74, Issue 18, 2010, Pages 1410-1411

  Bourdette, Dennis ^a   Whitham, Ruth ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON BETA SERINE; MITOXANTRONE;

ACUTE LEUKEMIA; CONGESTIVE HEART FAILURE; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; EDITORIAL; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; IMMUNOTHERAPY; MORTALITY; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SIDE EFFECT;

EID: 77951809940     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181dc1b36     Document Type: Editorial

References (7)

1. Hartung HP, Gonsett R, MIMS Study Group. Mitox-antrone in progressive multiple sclerosis (MS): a placebo-controlled randomized, observer-blind European phase III multicenter trial: clinical results. Mult Scler 1998;4:325.
2. Krapf H, Morriessey SP, Zenker O, et al. Mitoxantrone in progressive multiple sclerosis (MS): a placebo-controlled randomized, observer-blind European phase III multi-center trial: MRI results. Mult Scler 1998;4:380.
3. Hartung HP, Gonsett R, Konig N, et al. Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomized, multicentre trial. Lancet 2002; 360:2018-2025.
4. Goodin DS, Arnason BG, Coyle PK, et al. The use of mitoxantrone (Novantrone) for the treatment of multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2003;61:1332-1338.
5. European Study Group on Interferon/3-1b in Secondary Progressive MS. Placebo-controlled multicentre randomized trial of interferon b-1b in treatment of secondary progressive multiple sclerosis. Lancet 1998;352:1491-1497.
6. The North American Study Group in Interferon/3-1b in Secondary Progressive MS. Interferon beta-1b in secondary progressive MS: results from a 3-year controlled study. Neurology 2004;63:1788-1795.
7. Marriott JJ, Miyasaki JM, Gronseth G, O'Connor PW. Evidence report: the efficacy and safety of mitoxantrone (Novantrone) in the treatment of multiple sclerosis: Report of the Therapeutics and Technology Subcommittee of the American Academy of Neurology. Neurology 2010; 74:1463-1470.